This finding is remarkable since ACE inhibitors and ARBs not only belong to the standard therapy for hypertension and CAD, but are also known to slow down kidney disease progression and to improve proteinuria in diabetic nephropathy [16,32]. Here, ACE is linked to diabetic kidney disease.